Peritoneal carcinomatosis of unknown primary site: a case report of metastatic mucinous adenocarcinoma
DOI:
https://doi.org/10.18203/2349-2902.isj20261177Keywords:
Mucinous adenocarcinoma, Cancer of unknown primary, Peritoneal carcinomatosis, Thromboembolism, Tumor markersAbstract
Metastatic mucinous adenocarcinoma, a distinct subtype associated with extensive mucin production presents diagnostic and therapeutic challenges. This case involves a 21-year-old male with high-grade mucinous adenocarcinoma manifesting as cancer of unknown primary site, characterized by widespread peritoneal carcinomatosis and rapid progression despite systemic chemotherapy. The tumor’s aggressive behavior and thromboembolic complications underscore the need for tailored, multidisciplinary management strategies.
References
Huang A, Yang Y, Shi JY, Li YK, Xu JX, Cheng Y, et al. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer. World J Gastrointest Surg. 2021;13(12):1567-73.
Remo A, Fassan M, Vanoli A, Bonetti LR, Barresi V, Tatangelo F, et al. Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes. Cancers (Basel). 2019;11(7):1036.
Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol. 2012;3(3):153-73.
Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, et al. Diagnosis of digestive system tumours. Int J Cancer. 2021;148(5):1040-50.
Corfield AP, Carroll D, Myerscough N, Probert CS. Mucins in the gastrointestinal tract in health and disease. Front Biosci. 2001;6:d1321-57.
Lee NK, Kim S, Kim HS, Jeon TY, Kim GH, Kim DU, et al. Spectrum of mucin-producing neoplastic conditions of the abdomen and pelvis: cross-sectional imaging evaluation. World J Gastroenterol. 2011;17(43):4757-71.
Grotz TE, Royal RE, Mansfield PF, Overman MJ, Mann GN, Robinson KA, et al. Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade. World J Gastrointest Oncol. 2017;9(9):354-61.
Mekenkamp LJM, Heesterbeek KJ, Koopman M, Tol J, Teerenstra S, Venderbosch S, et al. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer. 2012;48(4):501-9.
Hu FJ, Li YJ, Zhang L, Ji DB, Liu XZ, Chen YJ, et al. Single-cell profiling reveals differences between human classical adenocarcinoma and mucinous adenocarcinoma. Commun Biol. 2023;6(1):15.
Tomuleasa C, Zaharie F, Muresan MS, Pop L, Fekete Z, Dima D, et al. How to Diagnose and Treat a Cancer of Unknown Primary Site. J Gastrointestin Liver Dis. 2017;26(1):69-79.
Walker A, Fang CS, Schroff C, Serrano J, Vasudevaraja V, Yang Y, et al. Deep learning-based classifier for carcinoma of unknown primary using methylation quantitative trait loci. J Neuropathol Exp Neurol. 2025;84(2):147-54.
Lambert LA. Looking up: Recent advances in understanding and treating peritoneal carcinomatosis. CA Cancer J Clin. 2015;65(4):283-98.
Coccolini F, Gheza F, Lotti M, Virzì S, Iusco D, Ghermandi C, et al. Peritoneal carcinomatosis. World J Gastroenterol. 2013;19(41):6979-94.
Halabi HE, Gushchin V, Francis J, Athas N, MacDonald R, Nieroda C, et al. Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer. Ann Surg Oncol. 2012;19(1):122-5.
Delord JP, Pierga JY, Dieras V, Bertheault-Cvitkovic F, Turpin FL, Lokiec F, et al. A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours. Br J Cancer. 2005;92(5):820-6.
Downloads
Published
How to Cite
Issue
Section
